Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2013
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy
Imke Satzger, Annette Degen, Hiba Asper, et al.
Journal of Dermatological Science
|
September 18, 2018
The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes
Katrin Schaper-Gerhardt, Antje Walter, Christina Schmitz-Rode, et al.
International Journal of Cancer
|
August 8, 2007
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha
Imke Satzger, Andre Meier, Florian Schenck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 13, 2014
Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients
Mareike Alter, Imke Satzger, Harald Schrem, et al.
Dermatology (Basel, Switzerland)
|
December 10, 2009
Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature
Imke Satzger, Uta Küttler, Bernward Völker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Reply to N. Rompoti et al
Imke Satzger, Annette Degen, Hiba Asper, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 21, 2010
The hand-foot-syndrome associated with medical tumor therapy - classification and management
Annette Degen, Mareike Alter, Florian Schenck, et al.
International Journal of Cancer
|
October 16, 2009
MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma
Imke Satzger, Anika Mattern, Uta Kuettler, et al.
Experimental Dermatology
|
June 22, 2012
microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells
Imke Satzger, Anika Mattern, Uta Kuettler, et al.
Journal of Skin Cancer
|
April 16, 2019
Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation
Nikolai Gräger, Mareike Leffler, Jens Gottlieb, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2013
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy
Imke Satzger, Annette Degen, Hiba Asper, et al.
Journal of Dermatological Science
|
September 18, 2018
The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes
Katrin Schaper-Gerhardt, Antje Walter, Christina Schmitz-Rode, et al.
International Journal of Cancer
|
August 8, 2007
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha
Imke Satzger, Andre Meier, Florian Schenck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 13, 2014
Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients
Mareike Alter, Imke Satzger, Harald Schrem, et al.
Dermatology (Basel, Switzerland)
|
December 10, 2009
Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature
Imke Satzger, Uta Küttler, Bernward Völker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Reply to N. Rompoti et al
Imke Satzger, Annette Degen, Hiba Asper, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 21, 2010
The hand-foot-syndrome associated with medical tumor therapy - classification and management
Annette Degen, Mareike Alter, Florian Schenck, et al.
International Journal of Cancer
|
October 16, 2009
MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma
Imke Satzger, Anika Mattern, Uta Kuettler, et al.
Experimental Dermatology
|
June 22, 2012
microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells
Imke Satzger, Anika Mattern, Uta Kuettler, et al.
Journal of Skin Cancer
|
April 16, 2019
Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation
Nikolai Gräger, Mareike Leffler, Jens Gottlieb, et al.
Page
of 6